Geneia Data Intelligence Lab
At its heart, the Geneia Data Intelligence Lab (GDI Lab) uses leading-edge data science to drive lower healthcare costs and improve health outcomes.
Our lab prioritizes projects that address major cost drivers and enable our clients – health plans, hospitals, physicians and their value-based partners – to identify, stratify and predict high-cost patients and conditions such as heart failure and diabetes.
Our models help clients to intervene earlier with patients whose risk is expected to rise and/or who are at risk for major, expensive conditions, allowing healthcare organizations to mitigate future costs while improving the health of those they serve.
Learn how GDI Lab develops and implements predictive models to improve population health from two of Geneia’s leaders. Fred Rahmanian, chief analytics and technology officer will walk you through how AI models are developed and refined. He focuses on three new AI models that predict complications and severe impacts for type 2 diabetes, heart failure and COVID-19.
Fred is joined by Shelley Riser, vice president of consulting service and clinical innovation. Shelley shares best practices for putting AI models into practice to improve population health. As a bonus, she discusses how AI is helping her develop more effective care management programs.
This presentation was originally delivered as part of a Population Health Alliance virtual event on May 20, 2020.